NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Mantis Biotechnology

Mantis Biotechnology

Private
New York City, New YorkHealthcare & Life Scienceshttps://mantisbiotech.com/

Last Round

Seed

Mar 29, 2026

Total Funding Raised

$13.7M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Mantis Biotechnology is a biotechnology and artificial intelligence company that provides a foundational infrastructure layer for building human-in-computer models by unifying fragmented data sources to create validated digital twins.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Synthetic Data, Medical Devices, Medical AI, Clinical Trials

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Infrastructure

Keywords

digital twinsynthetic databiomedical simulationphysics-based modelingmedical device testingpredictive modelingin silico trialsclinical trial simulationFDA submissionbiotech infrastructureAI for healthcarehuman physiology modelingdigital healthmedtechAI agent security

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Mantis Biotechnology Comps

Public and private peers based on sector, stage, and business model.

Mantis Biotechnology comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Mantis Biotechnology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 29, 2026
SeedJan 30, 2026

Key People

Founding team and executive leadership

Georgia Witchel

Chief Executive Officer

Executive Team

Mantis Biotechnology Investors

Notable investors and investment history

Mantis Biotechnology investors
InvestorRounds
DecibelSeed
Pioneer FundSeed
FenwickSeed
Y CombinatorSeed
Liquid 2 VenturesSeed
StoryHouse VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 30, 2026

    $6.3M round led by Decibel.

Mantis Biotechnology Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Mantis Biotechnology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Mantis Biotechnology's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range5
Year Founded2025
Last FundingMar 29, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.